Marex Group plc bought a new position in MetLife, Inc. (NYSE:MET – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 8,256 shares of the financial services provider’s stock, valued at approximately $664,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of MET. Quaker Wealth Management LLC grew its holdings in shares of MetLife by 198.2% during the second quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock worth $27,000 after buying an additional 672 shares in the last quarter. MTM Investment Management LLC acquired a new position in MetLife during the 2nd quarter worth approximately $37,000. GFG Capital LLC bought a new position in shares of MetLife during the 2nd quarter worth approximately $38,000. Abound Wealth Management raised its holdings in shares of MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 424 shares during the last quarter. Finally, Legend Financial Advisors Inc. bought a new stake in shares of MetLife in the second quarter worth $40,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Price Performance
Shares of NYSE MET opened at $82.08 on Monday. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. The business’s 50 day moving average price is $78.47 and its two-hundred day moving average price is $78.76. The company has a market cap of $54.08 billion, a PE ratio of 15.46, a price-to-earnings-growth ratio of 0.79 and a beta of 0.76. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $88.09.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th were issued a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Tuesday, November 4th. MetLife’s payout ratio is currently 42.75%.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. Piper Sandler downgraded MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price on the stock. in a research report on Friday, September 19th. UBS Group reduced their price target on MetLife from $96.00 to $95.00 and set a “buy” rating for the company in a research report on Thursday, November 6th. Keefe, Bruyette & Woods lowered their price target on MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of MetLife in a research note on Monday, December 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, MetLife has an average rating of “Moderate Buy” and a consensus target price of $94.60.
Check Out Our Latest Stock Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Most Volatile Stocks, What Investors Need to Know
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Market Cap Calculator: How to Calculate Market Cap
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
